|
|
3420 Central Expressway
Santa Clara, CA 95051 USA
phone:408-731-5000
fax:408-731-5380
|
|
| Symbol |
AFFX |
| Exchange |
NASDAQ |
| Founded |
1980 |
| Employees |
|
|
|
| www.affymetrix.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Genetic analysis; genetic assays |
|
| Management |
| Kevin M. King, , Affymetrix President and CEO; Stephen P.A. Fodor, Ph.D., Executive Chairman; John C. Batty, Chief Financial Officer and Executive Vice President of Finance; Rick Runkel, Executive Vice President, General Counsel and Secretary |
| |
|
|
|
|
|
|
|
| Keywords |
| genotyping, genome, axiom, cytogenetics, resequencing |
|
|
|
| Description |
|
Affymetrix introduced highly parallel genetic assays to the marketplace by commercializing the first DNA microarray in the late 1980s. Today researchers around the world use Affymetrix technologies to better understand the role that genes play in disease, the effectiveness and safety of therapies, and many other biological factors that affect human well-being. Affymetrix technology has been used to make groundbreaking discoveries to help the scientific and medical communities investigate conditions such as infertility, HIV, Parkinson's disease, diabetes, malaria, cancer, and many others. |
|
| Products / Services |
The Company has developed and intends to establish its GeneChip system and related microarray technology as the platform of choice for acquiring, analyzing and managing complex genetic information.
|
|
| Technology / Differentiation |
| Their products are based on semiconductor manufacturing techniques combined with advances in combinatorial chemistry to build vast amounts of biological data on a small glass chip. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
